Nationwide Data on the Characteristics of Linked-to-Care Chronic Hepatitis B in Korea

Young Cheol Ju1, Dae Won Jun1,2, Eileen L Yoon2

  • 1Department of Translational Medicine, Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul 04763, Korea.

Insights

Only 35.8% of chronic hepatitis B (CHB) patients in Korea linked to care, with lower rates in men and younger adults. Targeted interventions are needed for males in urban areas to improve CHB care linkage.

Area of Science:

  • Hepatology
  • Public Health
  • Epidemiology

Background:

  • Linkage-to-care rates for chronic hepatitis B (CHB) are not well understood.
  • Effective CHB management requires timely linkage to ongoing medical care.
  • Understanding patient characteristics associated with linkage is crucial for public health interventions.

Purpose of the Study:

  • To determine the proportion and characteristics of CHB patients linked to care in Korea.
  • To identify demographic and geographic factors influencing linkage-to-care rates.
  • To analyze the long-term outcomes of CHB patients who are linked to care.

Main Methods:

  • Retrospective analysis of Korean National Health Insurance Service claims data (2002-2018).
  • Inclusion criteria: CHB patients with at least two diagnostic visits between 2002-2006, without prior malignancy.
  • Follow-up until 2018 to assess linkage status and outcomes.

Main Results:

  • A total of 553,085 CHB patients were analyzed, with a linkage-to-care rate of 35.8%.
  • Linkage rates were lower in men (35.7%) vs. women (36.0%) and lowest in the 20s age group (29.4%).
  • Higher linkage rates were observed in rural areas compared to metropolitan areas (p < 0.0001).

Conclusions:

  • Two-thirds of CHB patients in Korea are not linked to care, highlighting a significant public health gap.
  • Interventions should target males, urban dwellers, and individuals not in life transition periods to improve CHB care linkage.
  • Linked CHB patients had a 15-year cumulative incidence of hepatocellular carcinoma of 18.2% and overall survival of 93.8%.

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
141
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
24
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.4K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
157
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
409
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
162